ScreenerHero

0HS8 Lisata Therapeutics, Inc.

LSE · GB · Healthcare · Biotechnology · lisata.com
1.150USD-8.00%Mkt Cap: —P/E: —

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational prod…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap—
Enterprise Value566.67K USD
Revenue (TTM)100.00K USD
Gross Profit100.00K USD
Net Income (TTM)-14.62M USD
Revenue/Share0.01 USD
Last Price1.150 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees21
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.04
EV/Revenue5.67
P/S—
P/B1.27
EPS (TTM)-0.39
EPS (Forward)—
52W Range
1.0702% of range5.100
52W High5.100 USD
52W Low1.070 USD
Profitability
Gross Margin100.00%
Oper. Margin-16426.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-101.66%
ROA-56.74%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.32M USD
CapEx (TTM)—
FCF Margin-8100.25%
FCF Yield—
Net Debt-10.44M USD
Net Debt/EBITDA0.64
Balance Sheet
Debt/Equity—
Current Ratio3.69
Quick Ratio3.56
Book Value/Sh0.90 USD
Cash/Share1.16 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.066667:1
Split DateSep 15, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float6.61M
Insiders22.26%
Institutions13.41%
Technical
SMA 502.587 (-55.6%)
SMA 2002.902 (-60.4%)
Beta0.94
S&P 52W Chg15.78%
Avg Vol (30d)3.31K
Avg Vol (10d)402
Technical Indicators
RSI (14)33.3
MACD-0.2590
MACD Signal-0.2812
MACD Hist.+0.0222
BB Upper1.874 USD
BB Middle1.541 USD
BB Lower1.208 USD
BB Width43.20%
ATR (14)0.1850 USD
Vol Ratio (20d)0.01x